SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer-Reference-Cited by-同舟云学术

SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer

Published:2014-05-21 Issue:7504 Volume:510 Page:283-287
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Mazur Pawel K.,Reynoird Nicolas,Khatri Purvesh,Jansen Pascal W. T. C.,Wilkinson Alex W.,Liu Shichong,Barbash Olena,Van Aller Glenn S.,Huddleston Michael,Dhanak Dashyant,Tummino Peter J.,Kruger Ryan G.,Garcia Benjamin A.,Butte Atul J.,Vermeulen Michiel,Sage Julien,Gozani Or

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature13320.pdf

Reference48 articles.

1. Helin, K. & Dhanak, D. Chromatin proteins and modifications as drug targets. Nature 502, 480–488 (2013)

2. Watanabe, T. et al. Differential gene expression signatures between colorectal cancers with and without KRAS mutations: crosstalk between the KRAS pathway and other signalling pathways. Eur. J. Cancer 47, 1946–1954 (2011)

3. Gaedcke, J. et al. Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas. Genes Chromosom. Cancer 49, 1024–1034 (2010)

4. Hamamoto, R. et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nature Cell Biol. 6, 731–740 (2004)

5. Pylayeva-Gupta, Y., Grabocka, E. & Bar-Sagi, D. RAS oncogenes: weaving a tumorigenic web. Nature Rev. Cancer 11, 761–774 (2011)

Cited by 327 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smyd3-mediated immuno-modulation in HPV-negative head and neck squamous cell carcinoma mouse models;iScience;2024-09

2. MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities;International Journal of Molecular Sciences;2024-08-29

3. The modification role and tumor association with a methyltransferase: KMT2C;Frontiers in Immunology;2024-08-06

4. Matrix stiffness-dependent PD-L2 deficiency improves SMYD3/xCT-mediated ferroptosis and the efficacy of anti-PD-1 in HCC;Journal of Advanced Research;2024-08

5. Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives;Biomarker Research;2024-07-30